Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation

QR Code

Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation

Aim. To compare anti-Xa plasma activity levels in patients with acute coronary syndrome (ACS) and no ST segment elevation (non-STE ACS), receiving enoxaparin, nadroparin, or dalteparin. Material and methods. In total, 90 patients with non-STE ACS were divided into three groups (n=30 in each group),...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. M. Linchak, V. S. Popov, K. F. Kim
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	acute coronary syndrome enoxaparin dalteparin nadroparin anti-xa activity
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1462
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DEVELOPMENT, VALIDATION AND APPLICATION OF ANTI-Xa- AND ANTI-IIa-ENOXAPARINE SODIUM ASSAY
by: B. Yu. Margaeva, et al.
Published: (2019-01-01)

FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
by: G. V. Mardaryan, et al.
Published: (2015-09-01)

UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
by: O. V. Krikunova, et al.
Published: (2018-03-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

POSSIBILITIES OF USING LOW-MOLECULAR-WEIGHT HEPARIN IN THE COMPLEX TREATMENT OF WOMEN WITH TUMORS OF THE REPRODUCTIVE SYSTEM
by: A. G. Kedrova, et al.
Published: (2017-06-01)

PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION
by: A. V. Syrov, et al.
Published: (2010-04-01)

Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients – 2024: Council of Experts resolution
by: А. S. Petrikov, et al.
Published: (2024-08-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

Considerations for the Bioanalytical Part of Equivalence Studies of Biosimilar Nadroparin Calcium
by: V. M. Kosman, et al.
Published: (2023-03-01)

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01)

Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?
by: I. S. Yavelov
Published: (2011-12-01)

Clusters of patients with non-ST-segment elevation acute coronary syndrome depending on the laboratory data
by: D. N. Nedbaeva, et al.
Published: (2024-08-01)

Laboratory Evaluation of the Platelet Component of Hemostasis in acute Coronary Syndrome With ST Segment Elevation
by: D. Markhulia, et al.
Published: (2025-04-01)

INHIBITION OF THE FACTOR XA (WITH RIVAROXABAN) SLOW DOWN PROGRESSION, PREVENTS COMPLICATION AND DECREASE MORTALITY IN CORONARY HEART DISEASE
by: V. N. Khirmanov
Published: (2018-04-01)

REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION
by: A. L. Alyavi, et al.
Published: (2016-01-01)

RESULTS OF STAGED ENDOVASCULAR MYOCARDIAL REVASCULARISATION IN PATIENTS TREATED FOR ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION AND MULTIVESSEL DISEASE
by: Alexander V. Bocharov, et al.
Published: (2019-07-01)

Development and attestation of a standard sample of calcium nadroparin
by: A. V. Zykova, et al.
Published: (2024-06-01)

2024 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation electrocardiogram
by: O. V. Averkov, et al.
Published: (2025-07-01)

Revascularization of myocardial infarction without ST segment elevation in multivessel coronary artery disease
by: Sh. J. Khalilov, et al.
Published: (2024-10-01)

Cardiometabolic risk factors in predicting obstructive coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
by: B. I. Geltser, et al.
Published: (2021-12-01)

Results of coronary bypass surgery performed in the early stages of non-ST segment elevation acute coronary syndrome
by: Yu. V. Neverova, et al.
Published: (2019-09-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

Efficient Marker-Assisted Pyramiding of <i>Xa21</i> and <i>Xa23</i> Genes into Elite Rice Restorer Lines Confers Broad-Spectrum Resistance to Bacterial Blight
by: Yao Li, et al.
Published: (2025-07-01)

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
by: . .
Published: (2016-03-01)

TREATMENT OF THE ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AT THE PRE-HOSPITAL CARE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Paradoxes of non-ST-segment elevation acute coronary in real-life clinical practice settings
by: A. K. Nesova, et al.
Published: (2024-04-01)

DEATH CAUSES AND THEIR PREDICTION IN PATIENTS WITH THE ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME AND PRE-HOSPITAL THROMBOLYSIS
by: S. N. Morozov, et al.
Published: (2013-04-01)

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study
by: Zahra Sahraei, et al.
Published: (2025-01-01)

Optimising the treatment of patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (1970-01-01)

Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
by: O. L. Barbarash, et al.
Published: (2021-11-01)

Heparin, Heparin-like Molecules, and Heparin Mimetics in Breast Cancer: A Concise Review
by: Diego R. Gatica Portillo, et al.
Published: (2025-07-01)

TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: N. A. Novikova, et al.
Published: (2016-01-01)

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
by: J.-P. Collet, et al.
Published: (2021-04-01)

ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
by: A. L. Komarov, et al.
Published: (2016-01-01)

2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
by: O. L. Barbarash, et al.
Published: (2021-05-01)

Gender-related features of reperfusion therapy in patients with ST segment elevation myocardial infarction
by: O. L. Barbarash, et al.
Published: (1970-01-01)

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY
by: O. V. Reshetko, et al.
Published: (2016-01-01)

CASE OF PSEUDOCORONARY PRESENTATION OF MYOCARDITIS WITH ST SEGMENT ELEVATION
by: S. B. Gomboeva, et al.
Published: (2016-11-01)

Clinical profile of patients with non-ST segment elevation acute coronary syndrome: experience of a regional vascular center
by: A. K. Nesova, et al.
Published: (2024-09-01)

CLINICAL ASPECTS OF PATIENT SELECTION FOR CORONARY ANGIOGRAPHY IN NON-ST ELEVATION ACUTE CORONARY SYNDROME
by: K. A. Kireev
Published: (2015-09-01)